Abstract
Neurotransmitters play essential roles in regulating neural circuit dynamics both in the central nervous system as well as at the peripheral, including the gastrointestinal tract1,2,3. Their real-time monitoring will offer critical information for understanding neural function and diagnosing disease1,2,3. However, bioelectronic tools to monitor the dynamics of neurotransmitters in vivo, especially in the enteric nervous systems, are underdeveloped. This is mainly owing to the limited availability of biosensing tools that are capable of examining soft, complex and actively moving organs. Here we introduce a tissue-mimicking, stretchable, neurochemical biological interface termed NeuroString, which is prepared by laser patterning of a metal-complexed polyimide into an interconnected graphene/nanoparticle network embedded in an elastomer. NeuroString sensors allow chronic in vivo real-time, multichannel and multiplexed monoamine sensing in the brain of behaving mouse, as well as measuring serotonin dynamics in the gut without undesired stimulations and perturbing peristaltic movements. The described elastic and conformable biosensing interface has broad potential for studying the impact of neurotransmitters on gut microbes, brain–gut communication and may ultimately be extended to biomolecular sensing in other soft organs across the body.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Vitamin D modulation of brain-gut-virome disorder caused by polystyrene nanoplastics exposure in zebrafish (Danio rerio)
Microbiome Open Access 27 November 2023
-
The ultra-thin, minimally invasive surface electrode array NeuroWeb for probing neural activity
Nature Communications Open Access 04 November 2023
-
Voltammetry in the spleen assesses real-time immunomodulatory norepinephrine release elicited by autonomic neurostimulation
Journal of Neuroinflammation Open Access 17 October 2023
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout




Data availability
The datasets generated during and/or analysed in this study are available from the corresponding author on reasonable request. The method and source code for the ex vivo gut segment diameter mapping recipe is provided in the Supplementary Information. Source data are provided with this paper.
References
Patriarchi, T. et al. Ultrafast neuronal imaging of dopamine dynamics with designed genetically encoded sensors. Science 360, eaat4422 (2018).
Nakatsuka, N. et al. Aptamer–field-effect transistors overcome Debye length limitations for small-molecule sensing. Science 362, 319–324 (2018).
Kishida, K. T. et al. Subsecond dopamine fluctuations in human striatum encode superposed error signals about actual and counterfactual reward. Proc. Natl Acad. Sci. 113, 200–205 (2016).
Wise, R. A. Dopamine, learning and motivation. Nat. Rev. Neurosci. 5, 483–494 (2004).
Naughton, M., Mulrooney, J. B. & Leonard, B. E. A review of the role of serotonin receptors in psychiatric disorders. Hum. Psychopharmacol. 15, 397–415 (2000).
Hyman, S. E. & Malenka, R. C. Addiction and the brain: the neurobiology of compulsion and its persistence. Nat. Rev. Neurosci. 2, 695–703 (2001).
Russo, S. J. & Nestler, E. J. The brain reward circuitry in mood disorders. Nat. Rev. Neurosci. 14, 609–625 (2013).
Cummings, J. L. Depression and Parkinson’s disease: a review. Am. J. Psychiatry 149, 443–454 (1992).
Spohn, S. N. & Mawe, G. M. Non-conventional features of peripheral serotonin signalling-the gut and beyond. Nat. Rev. Gastroenterol. Hepatol. 14, 412–420 (2017).
Furness, J. B. The enteric nervous system and neurogastroenterology. Nat. Rev. Gastroenterol. Hepatol. 9, 286–294 (2012).
Marvin, J. S. et al. An optimized fluorescent probe for visualizing glutamate neurotransmission. Nat. Methods 10, 162–170 (2013).
Sun, F. et al. A genetically encoded fluorescent sensor enables rapid and specific detection of dopamine in flies, fish, and mice. Cell 174, 481–496.e19 (2018).
Robinson, D. L., Venton, B. J., Heien, M. L. A. V. & Wightman, R. M. Detecting subsecond dopamine release with fast-scan cyclic voltammetry in vivo. Clin. Chem. 49, 1763–1773 (2003).
Hashemi, P., Dankoski, E. C., Petrovic, J., Keithley, R. B. & Wightman, R. M. Voltammetric detection of 5-hydroxytryptamine release in the rat brain. Anal. Chem. 81, 9462–9471 (2009).
Schwerdt, H. N. et al. Long-term dopamine neurochemical monitoring in primates. Proc. Natl Acad. Sci. 114, 13260–13265 (2017).
Taylor, I. M. et al. Enhanced dopamine detection sensitivity by PEDOT/graphene oxide coating on in vivo carbon fiber electrodes. Biosens. Bioelectron. 89, 400–410 (2017).
Clark, J. J. et al. Chronic microsensors for longitudinal, subsecond dopamine detection in behaving animals. Nat. Methods 7, 126–129 (2010).
Moran, R. J. et al. The protective action encoding of serotonin transients in the human brain. Neuropsychopharmacology 43, 1425–1435 (2018).
Bang, D. et al. Sub-second dopamine and serotonin signaling in human striatum during perceptual decision-making. Neuron 108, 999–1010.e6 (2020).
Minev, I. R. et al. Electronic dura mater for long-term multimodal neural interfaces. Science 347, 159–163 (2015).
Vázquez-Guardado, A., Yang, Y., Bandodkar, A. J. & Rogers, J. A. Recent advances in neurotechnologies with broad potential for neuroscience research. Nat. Neurosci. 23, 1522–1536 (2020).
Hong, G. & Lieber, C. M. Novel electrode technologies for neural recordings. Nat. Rev. Neurosci. 20, 330–345 (2019).
Deng, J. et al. Electrical bioadhesive interface for bioelectronics. Nat. Mater. 20, 229–236 (2021).
Frank, J. A., Antonini, M. J. & Anikeeva, P. Next-generation interfaces for studying neural function. Nat. Biotechnol. 37, 1013–1023 (2019).
Lee, S. et al. Ultrasoft electronics to monitor dynamically pulsing cardiomyocytes. Nat. Nanotechnol. 14, 156–160 (2019).
Terem, I. et al. Revealing sub-voxel motions of brain tissue using phase-based amplified MRI (aMRI). Magn. Reson. Med. 80, 2549–2559 (2018).
Spencer, K. C. et al. Characterization of mechanically matched hydrogel coatings to improve the biocompatibility of neural implants. Sci. Rep. 7, 1952 (2017).
Schwerdt, H. N. et al. Subcellular probes for neurochemical recording from multiple brain sites. Lab Chip 17, 1104–1115 (2017).
Mazzuoli-Weber, G. & Schemann, M. Mechanosensitivity in the enteric nervous system. Front. Cell. Neurosci. 9, 408 (2015).
Patel, B. A., Bian, X., Quaiserová-Mocko, V., Galligan, J. J. & Swain, G. M. In vitro continuous amperometric monitoring of 5-hydroxytryptamine release from enterochromaffin cells of the guinea pig ileum. Analyst 132, 41–47 (2007).
Osorio, N. & Delmas, P. Patch clamp recording from enteric neurons in situ. Nat. Protoc. 6, 15–27 (2011).
Bucher, E. S. & Wightman, R. M. Electrochemical analysis of neurotransmitters. Annu. Rev. Anal. Chem. 8, 239–261 (2015).
Xu, C., Wu, F., Yu, P. & Mao, L. In vivo electrochemical sensors for neurochemicals: recent update. ACS Sens. 4, 3102–3118 (2019).
Kinloch, I. A., Suhr, J., Lou, J., Young, R. J. & Ajayan, P. M. Composites with carbon nanotubes and graphene: an outlook. Science 362, 547–553 (2018).
Sun, D. et al. Electrodeposition synthesis of a NiO/CNT/PEDOT composite for simultaneous detection of dopamine, serotonin, and tryptophan. Sens. Actuators B Chem. 259, 433–442 (2018).
Yang, W. et al. Enhancing electrochemical detection of dopamine via dumbbell-like FePt–Fe3O4 nanoparticles. Nanoscale 9, 1022–1027 (2017).
Fernandes, D. M. et al. Novel electrochemical sensor based on N-doped carbon nanotubes and Fe3O4 nanoparticles: simultaneous voltammetric determination of ascorbic acid, dopamine and uric acid. J. Colloid Interface Sci. 432, 207–213 (2014).
Salinas-Hernández, X. I. et al. Dopamine neurons drive fear extinction learning by signaling the omission of expected aversive outcomes. eLife 7, e38818 (2018).
Bertrand, P. P., Hu, X., Mach, J. & Bertrand, R. L. Serotonin (5-HT) release and uptake measured by real-time electrochemical techniques in the rat ileum. Am. J. Physiol. Gastrointest. Liver Physiol. 295, G1228–G1236 (2008).
Bertrand, P. P. Real-time measurement of serotonin release and motility in guinea pig ileum. J. Physiol. 577, 689–704 (2006).
Bertrand, P. P. & Bertrand, R. L. Serotonin release and uptake in the gastrointestinal tract. Auton. Neurosci. 153, 47–57 (2010).
Bertrand, P. P. Real-time detection of serotonin release from enterochromaffin cells of the guinea-pig ileum. Neurogastroenterol. Motil. 16, 511–514 (2004).
Mawe, G. M. & Hoffman, J. M. Serotonin signalling in the gut—functions, dysfunctions and therapeutic targets. Nat. Rev. Gastroenterol. Hepatol. 10, 473–486 (2013).
Gershon, M. D. & Tack, J. The serotonin signaling system: from basic understanding to drug development for functional GI disorders. Gastroenterology 132, 397–414 (2007).
Okayasu, I. et al. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 98, 694–702 (1990).
Linden, D. R., Chen, J. X., Gershon, M. D., Sharkey, K. A. & Mawe, G. M. Serotonin availability is increased in mucosa of guinea pigs with TNBS-induced colitis. Am. J. Physiol. Gastrointest. Liver Physiol. 285, 761–768 (2003).
Padmanabhan, P., Grosse, J., Asad, A. B. M. A., Radda, G. K. & Golay, X. Gastrointestinal transit measurements in mice with 99mTc-DTPA-labeled activated charcoal using NanoSPECT-CT. EJNMMI Res. 3, 60 (2013).
Singh, M. K. & Bandyopadhyay, D. Design and synthesis of nanoporous perylene bis-imide linked metalloporphyrin frameworks and their catalytic activity. J. Chem. Sci. 128, 1–8 (2016).
Lin, J. et al. Laser-induced porous graphene films from commercial polymers. Nat. Commun. 5, 5714 (2014).
Metscher, B. D. MicroCT for comparative morphology: Simple staining methods allow high-contrast 3D imaging of diverse non-mineralized animal tissues. BMC Physiology 9, 11 (2009).
Roberts, J. G. & Sombers, L. A. Fast-scan cyclic voltammetry: chemical sensing in the brain and beyond. Anal. Chem. 90, 490–504 (2018).
Howard, C. D., Li, H., Geddes, C. E. & Jin, X. Dynamic nigrostriatal dopamine biases action selection. Neuron 93, 1436–1450.e8 (2017).
Stamford, J. A., Kruk, Z. L. & Millar, J. Striatal dopamine terminals release serotonin after 5-HTP pretreatment: in vivo voltammetric data. Brain Res. 515, 173–180 (1990).
Swamy, B. E. K. & Venton, B. J. Carbon nanotube-modified microelectrodes for simultaneous detection of dopamine and serotonin in vivo. Analyst 132, 876–884 (2007).
Jackson, B. P. & Mark Wightman, R. Dynamics of 5-hydroxytryptamine released from dopamine neurons in the caudate putamen of the rat. Brain Res. 674, 163–166 (1995).
Tatem, K. S. et al. Behavioral and locomotor measurements using an open field activity monitoring system for skeletal muscle diseases. J. Vis. Exp. 29, 51785 (2014).
Lynch, J. J., Castagné, V., Moser, P. C. & Mittelstadt, S. W. Comparison of methods for the assessment of locomotor activity in rodent safety pharmacology studies. J. Pharmacol. Toxicol. Methods 64, 74–80 (2011).
Hoibian, E., Florens, N., Koppe, L., Vidal, H. & Soulage, C. O. Distal colon motor dysfunction in mice with chronic kidney disease: putative role of uremic toxins. Toxins 10, 204 (2018).
Wirtz, S. et al. Chemically induced mouse models of acute and chronic intestinal inflammation. Nat. Protoc. 12, 1295–1309 (2017).
Tainaka, K. et al. Chemical landscape for tissue clearing based on hydrophilic reagents. Cell Rep. 24, 2196–2210.e9 (2018).
Swaminathan, M. et al. Video imaging and spatiotemporal maps to analyze gastrointestinal motility in mice. J. Vis. Exp. 2016, e53828 (2016).
Spear, E. T. et al. Altered gastrointestinal motility involving autoantibodies in the experimental autoimmune encephalomyelitis model of multiple sclerosis. Neurogastroenterol. Motil. 30, e13349 (2018).
Acknowledgements
This work was partly supported by the Stanford Bio-X Interdisciplinary Initiatives Seed Grants Program (IIP award) and the Wu Tsai Neuroscience Institute Big Idea Award. Part of this work was performed at the Stanford Nano Shared Facilities (SNSF), supported by the National Science Foundation under award ECCS-1542152. X.C. and L.Y. are partially supported by National Institutes of Health grants R01DA045664, R01MH116904 and R01HL150566, and X.C. is also supported by the Firmenich Next Generation Fund. Y.L. is supported by National Science Scholarship (A*STAR, Singapore). Part of the electrochemical measurement experiments during revision was conducted at Michigan State University. We thank N. G. Hollon and X. Jin from the Salk Institute for their help with the FSCV technique; G. Hennig (University of Vermont) for the design and use of Volumetry software; S. Baker and A. Zhang for their help on pig animal surgery; S. Das from the Julia Kaltschmidt lab for the help on the colonic motility assay setup; S. Rogalla for the endoscope imaging; T. Z. Gao for comments on the manuscript; and Y. Tsao, S. Chen and Y. Liu for their help on materials characterization.
Author information
Authors and Affiliations
Contributions
J.L., Y.L., X.C. and Z.B. conceived the project. J.L., Y.L., L.Y., X.C., Z.B., E.S.B. and A.H. designed the experiments. J.L. and Y.L. designed and fabricated the device and performed the mechanical, electrical and electrochemical measurements. K.W. synthesized the metalloporphyrin. J.L., Y.L. and Y.-Q.Z. performed the SEM, CT and photography. J.T. and G.C. performed the EELS, HRTEM, SEM and Raman characterizations. J.L., Y.L., L.Y., B.Z. and E.S.B. carried out the ex vivo experiments and animal studies. S.N. and L.B. contributed to the initial materials selection. M.D., A.-L.T. and J.C.Y.D. developed the pig animal model and protocol. W.X. helped to prepare the schematics. V.M. helped to analyse the voltammograms. T.L.L., B.C. and S.P.P. contributed to characterization of tissue responses. J.L., Y.L. and E.S.B. analysed the results. J.L., Y.L., X.C., Z.B. and J.B.-H.T. wrote the manuscript. All authors discussed the results and commented on the manuscript. All authors have given approval to the final version of the manuscript. Z.B. and X.C. directed the project.
Corresponding authors
Ethics declarations
Competing interests
J.L., Y.L. and Z.B. are inventors on a patent application (no. 63/085,720) submitted by the Board of Trustees of Stanford University.
Peer review
Peer review information
Nature thanks Giovanni Traverso and the other, anonymous, reviewers for their contribution to the peer review of this work.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Extended data figures and tables
Extended Data Fig. 1 Fabrication process of the NeuroString sensors.
a, Scheme showing the chemical structures of the polymer precursors and the laser carbonization process. b, Layout showing the dimensions of the multichannel NeuroString electrodes for the sensing in the brain. c, Fabrication process of the NeuroString for brain neurochemical sensing. (1) A polymer precursor solution containing a polyamic acid mixed with a metalloporphyrin (2.3 × 10−1 mM) was uniformly drop-casted (50 μl cm−2) as a film on a polyimide substrate. (2) The precursor film was annealed in air at 250 °C for 1 h to form the polyimide film. (3) The film surface was laser engraved by an Epilog Fusion M2 laser (power 6 W) to generate the graphene network with Fe3O4 or NiO nanoparticles. A HPDFO lens with a focal point of 0.001” (25.4 μm) can be used improve the resolution of the engraving. (4) A SEBS solution (H1062, 0.1 g ml−1 in toluene) was drop-casted on the graphene networks, which was then peeled off from the substrate and attached to another glass substrate when the SEBS side was in contact with glass. (5) Another SEBS layer (H1062, 0.1 g ml−1 in toluene) was spin-coated on top at 1,000 rpm, to form an encapsulation layer. (6) A high laser power of 30 W was subsequently used to cut into the desired size and shape and isolate the individual electrode strings with width 90 µm. (7) The electrode area is dip-coated in another elastomer solution (Kuraray LA3320, 0.1 g ml−1 in acetone) to fully encapsulate the graphene electrodes. (8) For implantation in the brain, the NeuroStrings were dip-coated in a pullulan solution (0.3 g ml−1) and dried overnight to form a rigid coating. (9) The tips of electrodes were cut by a razor blade to expose the cross sections of the graphene. To fully expose the graphene, the cross-sectional surfaces of electrodes were oxygen plasma-treated for 2 min (Technics Micro-RIE Series 800, 150 W, 200 mTorr). To avoid any electrochemical interference of the ascorbic acid from the biological fluids, the tips of the electrodes were dipped in a Nafion solution (0.5% in water/ethanol) to form a Nafion coating before use. (10) Dissolving of the pullulan in tissue finally releases the NeuroString as a soft implant. d, Layout showing the dimensions of the NeuroString electrodes for sensing in the gut. e, Fabrication process of the NeuroString for gut neurochemical sensing. (1) A polymer precursor solution containing a polyamic acid mixed with a metalloporphyrin (2.3 × 10−1 mM) was uniformly drop-casted (50 μl cm−2) as a film on a polyimide substrate. (2) The precursor film was annealed in air at 250 °C for 1 h to form the polyimide film. (3) The film surface was laser engraved by an Epilog Fusion M2 Laser (power 6 W) to generate the graphene network with Fe3O4 or NiO nanoparticles. (4) SEBS solution (H1062, 0.1 g ml−1 in toluene) was drop casted on the graphene networks to form graphene–SEBS composite, which was then delaminated and transferred from the substrate and flipped on another glass substrate. (5) Another SEBS layer (H1062, 0.1 g ml−1 in toluene) was spin-coated on top at 1,000 rpm, to form an encapsulation layer. (6) A high-power laser with power 30 W and 20% speed was used to cut the undesired part of the device. (7) For easier placing the mouse gut, a pullulan solution (0.1 g ml−1) was dip-coated on the electrodes and dried overnight to form the shuttle layer. (8) The ends of electrodes were cut using a razor blade to expose the cross sections of the graphene. To fully expose the graphene, the cross-sectional surfaces of electrodes were oxygen plasma-treated for 2 min. To avoid any interference of the ascorbic acid from the biological fluids, the tips of the electrodes were finally dipped in a Nafion solution (0.5% in water/ethanol) to form a Nafion coating before use. (9) Dissolving of the pullulan in tissue will release the NeuroString as a soft implant.
Extended Data Fig. 2 Characterization of the laser-induced graphene used in the NeuroString sensor.
a, SEM images showing the resolution of the laser fabrication process (laser power 6 W). Direct laser writing can achieve a resolution of about 100 μm, whereas individual structures smaller than 50 μm can be fabricated by the laser engraving (etching) process: for example, two laser cutting lines with a distance of 150 μm will lead to a free-standing electrode of width 50 μm. b–d, SEM images showing the graphene networks made by different laser powers. The graphene layer thicknesses are: 40–50 μm (laser power 6 W), 50–80 μm (laser power 9 W) and 120–150 μm (laser power 12 W). Thicker polyimide film will be carbonized at a higher laser power, so that the graphene layer increases. The SEM characterization was repeated and reproduced six times. e, High-resolution TEM of laser-induced graphene showing the characteristic 0.34-nm d-spacing between graphene sheets (laser power 6 W). The TEM characterization was repeated and reproduced three times. f, Normalized confocal Raman spectra (633-nm laser excitation) of a laser-induced graphene film made by different laser powers. The intensity profile indicates that higher laser power induced more defects in graphene. The higher D band at lower laser power is mainly owing to the more oxygen and graphene oxide present in the laser-induced graphene.
Extended Data Fig. 3 Characterization of the transition metal oxide nanoparticles involved in the NeuroString sensor.
a, TEM characterization of the laser-induced graphene decorated with Fe3O4 nanoparticles (laser power 6 W). The TEM characterization was repeated and reproduced three times. b, TEM intensity profile of the Fe3O4 nanocrystal shown in a. c, EELS analysis of the laser-induced graphene decorated with Fe3O4 nanoparticles (laser power 6 W). d, EELS mapping showing decoration of Fe3O4 nanoparticles on the graphene. e, TEM characterization of the laser-induced graphene decorated with NiO nanoparticles (laser power 6 W). The TEM characterization was repeated and reproduced three times. f, TEM intensity profile of the NiO nanocrystal shown in e. g, EELS analysis of the laser-induced graphene decorated with NiO nanoparticles (laser power 6 W).
Extended Data Fig. 4 Selectivity and sensitivity characterization of the NeuroString sensors.
a, b, Cyclic voltammetry backgrounds of different electrodes in PBS buffer (pH 7.4) (scan rate 400 V s−1). NeuroString has lower background current than the carbon fibre. c, Reaction mechanism of the dopamine and serotonin oxidation during FSCV measurement. d, Comparison of the selectivity of different electrodes for simultaneous dopamine and serotonin sensing using cyclic voltammetry. The cyclic voltammetry is performed in a solution with 500 nM dopamine and 500 nM serotonin in PBS (pH 7.4), with a scan rate of 10 V s−1. e, f, Normalized oxidation current (nA) of NeuroString (without and with Fe3O4 nanoparticles) and carbon nanofibres for dopamine and serotonin sensing (scan rate 400 V s−1). As the background current varies from 100 to 500 nA depending on the dimension, the \({\rm{normalized\; oxidation\; current}}=\frac{{\rm{Background\; current}}}{{\rm{Faradic\; current}}}\times 1,000\,{\rm{nA}}\); the background current is defined as the current value at 0.5 V. n = 5 different NeuroString electrodes were examined in independent measurements, box range: 25–75%. g, Concentration-dependent calibration response of NeuroString electrode to 5-HT using FSCV and chronoamperometry. (PBS buffer pH 7.4; chronoamperometry potential: 0.6 V, error bars are obtained from n = 6 different NeuroString electrodes examined in independent measurements.) Simultaneous and selective detection of DA and 5-HT. h, FSCV of various concentrations of 5-HT (100 nM, 250 nM, 500 nM, 750 nM, 1,000 nM) in 200 nM DA solution (dissolved in PBS buffer, pH 7.4); inset shows the linear plot of currents against concentrations of 5-HT. i, FSCV of various concentrations of DA (100 nM, 250 nM, 500 nM, 750 nM, 1,000 nM) in 200 nM 5-HT solution (dissolved in PBS buffer, pH 7.4); inset shows the linear plot of currents against concentrations of DA. Simultaneous and selective detection of NP, EP and 5-HT. j, FSCV of various concentrations of EP (100 nM, 250 nM, 500 nM, 750 nM, 1,000 nM) in 200 nM 5-HT and 200 nM EP solution (dissolved in PBS buffer, pH 7.4); inset shows the linear plot of currents against concentrations of EP. k, FSCV of various concentrations of 5-HT (100 nM, 250 nM, 500 nM, 750 nM, 1,000 nM) in 200 nM NP and 200 nM EP solution (dissolved in PBS buffer, pH 7.4); inset shows the linear plot of currents against concentrations of 5-HT. l, FSCV of various concentrations of NP (100 nM, 250 nM, 500 nM, 750 nM, 1,000 nM) in 200 nM 5-HT and 200 nM EP solution (dissolved in PBS buffer, pH 7.4); inset shows the linear plot of currents against concentrations of NP.
Extended Data Fig. 5 Measurement of the neurotransmitter release during fear conditioning and extinction training, and chronic stability of the NeuroString for neurotransmitter sensing.
a–d, Dopamine release in the NAc measured during various phases of a fear extinction task (NeuroStrings were implanted at least two weeks before the behaviour assay started). a, Trial structure for the fear extinction training. b, Percentage of freezing to the CS during the early extinction phase (E-Ext, 1–8 trials) and the late extinction phase (L-Ext, 9–15 trials) (n = 5 mice). The CS evoking lower freezing levels during the late phase indicated successful extinction learning. P-value 0.0005. c, Quantification of dopamine responses to the CS during habituation (before Cond.), the fear conditioning (an electric shock after the tone) and fear extinction phase (n = 5 mice). P-values: 0.0018 (shock), 0.003 (E-Ext), 0.0706 (L-Ext). d, Exemplar time-aligned dopamine signals from a mouse during each phase. e, Chronic measurement of dopamine in the NAc evoked by optogenetic stimulation of dopamine neurons in the VTA of DAT-Cre mice expressing ChR2 (error bars are obtained from measurements from n = 6 biologically independent mice). P-values: 0.9011 (week 4), 0.9926 (week 8), 0.6946 (week 12), 0.4462 (week 16). f, g, Representative measurements from a NeuroString electrode in a mouse across 16 weeks in the form of background-subtracted cyclic voltammogram (f) and the corresponding electrochemical impedance (g). P-values are calculated by paired two-tailed Student’s t-test: NS, P > 0.05; *P ≤ 0.05; **P ≤ 0.01; ***P ≤ 0.001.
Extended Data Fig. 6 Evaluation of NeuroString performance for serotonin sensing in the GI tract of rodents and large animals.
a, Setup of the colonic motility assay providing video imaging and spatiotemporal maps to analyse colonic motility of mice inserted with NeuroString ex vivo. Control is a mouse colon without anything inside the lumen. b, Representative H&E staining images showing the colon tissue of mice placed with a flexible Kapton (length 2 cm, width 800 μm, thickness 120 μm) film and a NeuroString with the same dimensions. The materials were placed in the colon of freely moving mice for 3 h before collecting the tissue. Damage to the tissue was clearly observed with flexible polyimide film implant. The H&E staining was repeated and reproduced for five mice. Open-field activity (average velocity) (c, d) and pellet output (e) over a 5-h period for mice with the colon acutely placed with a NeuroString or a flexible Kapton polyimide as control (n = 6). P-values: NeuroString (0.9689), polyimide (0.0004) in d; NeuroString (0.4895), polyimide (0.0015) in e. The dotted lines in c show 5-min trajectories of the mice. f, Photos showing NeuroString wrapped around a probe extended from one working channel of an endoscope (left) and the obtained endoscopy photo showing the NeuroString entering the colon lumen for serotonin sensing in a rat model (right). g, Representative serotonin concentration mapping in the rat colon (5 cm from the anus) collected by delivering the NeuroString into the colon lumen and slowly taking it out (error bar denotes ±standard deviation of the measurement results obtained from three channels). h, μ-CT images showing the NeuroString conformally loaded in the mouse colon. i, Representative H&E staining images showing the colon tissue of control mouse treated with saline water and colitis mouse with inflammation induced by DSS after 10 days of colitis development. The H&E staining was repeated and reproduced for five mice. j, Measured serotonin concentration in the colon tissue of control and DSS mice using enzyme-linked immunosorbent assay. P-value 0.0171. k, Layout of the NeuroString sensor for serotonin sensing in the pig colon. The sensor fabrication process is the same as that illustrated in Extended Data Fig. 1, except for the use of a large polyimide sheet (12” × 12”) as a substrate. l, Scheme and photo showing the multiple-site serotonin measurement in the intestine of a pig by NeuroString. m, Simultaneous serotonin sensing in different segments of the intestinal tract by multiple-channel NeuroString. n, o, Drug-induced luminal serotonin concentration change using fluoxetine (SSRI), MB, fluoxetine (SSRI) + MB and saline as control (n = 6 pigs). P-values: SSRI (0.5553), MB (0.3567), SSRI + MB (0.0099). P-values are calculated by paired two-tailed Student’s t-test: NS, P > 0.05; *P ≤ 0.05; **P ≤ 0.01; ***P ≤ 0.001.
Supplementary information
Supplementary Information
This file contains supplementary figures, code examples, legends for supplementary videos 1 and 2 and supplementary references.
Supplementary Data for Supplementary Figure 2
This file contains supplementary data for Supplementary Figure 2.
Supplementary Data for Supplementary Figure 3
This file contains supplementary data for Supplementary Figure 3.
Supplementary Data for Supplementary Figure 4
This file contains supplementary data for Supplementary Figure 4.
Rights and permissions
About this article
Cite this article
Li, J., Liu, Y., Yuan, L. et al. A tissue-like neurotransmitter sensor for the brain and gut. Nature 606, 94–101 (2022). https://doi.org/10.1038/s41586-022-04615-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41586-022-04615-2
This article is cited by
-
Artificial intelligence enhanced sensors - enabling technologies to next-generation healthcare and biomedical platform
Bioelectronic Medicine (2023)
-
Vitamin D modulation of brain-gut-virome disorder caused by polystyrene nanoplastics exposure in zebrafish (Danio rerio)
Microbiome (2023)
-
Voltammetry in the spleen assesses real-time immunomodulatory norepinephrine release elicited by autonomic neurostimulation
Journal of Neuroinflammation (2023)
-
Conformal in-ear bioelectronics for visual and auditory brain-computer interfaces
Nature Communications (2023)
-
In situ assembly of bioresorbable organic bioelectronics in the brain
Nature Communications (2023)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.